-IR- Database Guide
-IR- Database: Indiana Register

TITLE 71 INDIANA HORSE RACING COMMISSION

Emergency Rule
LSA Document #12-72(E)

DIGEST

Amends 71 IAC 8-1-4.2 regarding threshold levels. Amends 71 IAC 8.5-1-4.2 regarding threshold levels. Effective February 8, 2012.



SECTION 1. 71 IAC 8-1-4.2 IS AMENDED TO READ AS FOLLOWS:

71 IAC 8-1-4.2 Threshold levels

Authority: IC 4-31-3-9
Affected: IC 4-31-12


Sec. 4.2. The official blood (serum or plasma) sample may contain the following drug substances, their metabolites or analogs, and shall not exceed the threshold concentrations specified in this rule:
(1) The use of clenbuterol shall be permitted under the following conditions: Not to exceed the following permitted serum or plasma threshold concentrations twenty-five (25) picograms per milliliter of clenbuterol (or its metabolites) which are consistent with administration of FDA approved medication at the recommended labeled dose with a withdrawal time of seven (7) days: Standardbred - 25 picograms per milliliter. in serum or plasma.
(2) The use of firocoxib shall be permitted under the following conditions: Not to exceed forty (40) nanograms per milliliter of firocoxib (or its metabolites) in serum or plasma.
(3) The use of dimethylsulfoxide (DMSO) shall be permitted under the following conditions: Not to exceed ten (10) micrograms per milliliter of DMSO (or its metabolites) in serum or plasma which allows for topical administration of DMSO in accordance with 71 IAC 8-1-1 [section 1 of this rule].
(Indiana Horse Racing Commission; 71 IAC 8-1-4.2; emergency rule filed Jan 25, 2012, 12:20 p.m.: 20120201-IR-071120056ERA; emergency rule filed Feb 8, 2012, 12:01 p.m.: 20120215-IR-071120072ERA)


SECTION 2. 71 IAC 8.5-1-4.2 IS AMENDED TO READ AS FOLLOWS:

71 IAC 8.5-1-4.2 Threshold levels

Authority: IC 4-31-3-9
Affected: IC 4-31-12


Sec. 4.2. The official blood (serum or plasma) sample may contain the following drug substances, their metabolites or analogs, and shall not exceed the threshold concentrations specified in this rule:
(1) The use of clenbuterol shall be permitted under the following conditions:
(1) (A) Not to exceed the following permitted serum or plasma threshold concentrations of clenbuterol (or its metabolites): which are consistent with administration of FDA approved medication at the recommended labeled dose with a withdrawal time of seven (7) days: Thoroughbred – twenty-five (25) picograms per milliliter.
(2) (B) Not to exceed the following permitted serum or plasma threshold concentrations of clenbuterol (or its metabolites): which are consistent with administration of FDA approved medication at the recommended labeled dose with a withdrawal time of thirty (30) days: Quarter horse – two (2) picograms per milliliter.
(2) The use of firocoxib shall be permitted under the following conditions: Not to exceed forty (40) nanograms per milliliter of firocoxib (or its metabolites) in serum or plasma.
(3) The use of dimethylsulfoxide (DMSO) shall be permitted under the following conditions: Not to exceed ten (10) micrograms per milliliter of DMSO (or its metabolites) in serum or plasma which allows for topical administration of DMSO in accordance with 71 IAC 8.5-1-1 [section 1 of this rule].
(Indiana Horse Racing Commission; 71 IAC 8.5-1-4.2; emergency rule filed Jan 25, 2012, 12:20 p.m.: 20120201-IR-071120056ERA; emergency rule filed Feb 8, 2012, 12:01 p.m.: 20120215-IR-071120072ERA)


LSA Document #12-72(E)
Filed with Publisher: February 8, 2012, 12:01 p.m.

Posted: 02/15/2012 by Legislative Services Agency

DIN: 20120215-IR-071120072ERA
Composed: Oct 01,2014 4:58:05AM EDT
A PDF version of this document.